NCT07480876

Brief Summary

Does phonophoresis with glyceryl trinitrate gel have an effect in treatment of planter fasciitis patients?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Apr 2026Nov 2026

First Submitted

Initial submission to the registry

March 14, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 30, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

March 14, 2026

Last Update Submit

March 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ultrasonography

    Patients with plantar fasciitis also typically have a thickened fascia. This change could be related to the reparative process of microtears, fiber degeneration, or edema. The average thickness of the plantar fascia in healthy individuals is between 2.2 and 3.6 mm. In patients with plantar fasciitis, it ranges from 4.6 to 6.1 mm. In general, individuals with a plantar fascia thicker than 4 mm are considered to have plantar fasciitis.

    From enrollment to the end of treatment at 5 weeks

Secondary Outcomes (4)

  • visual analogue scale

    From enrollment to the end of treatment at 5 weeks

  • 6-Minu Walk Test

    From enrollment to the end of treatment at 5 weeks

  • Smartphone apps

    From enrollment to the end of treatment at 5 weeks

  • Arabic version of modified foot function index (FFI)

    From enrollment to the end of treatment at 5 weeks

Study Arms (2)

Phonophoresis group

EXPERIMENTAL

Ultrasound will be used in addition to topical glyceryl trinitrate gel and therapeutic exercises.

Other: Phonophoresis group

ultrasound only and Therapeutic exercises

ACTIVE COMPARATOR
Other: ultrasound only and Therapeutic exercises

Interventions

1. Patients will receive Phonophoresis with topical glyceryl trinitrate gel. Using pulsed ultrasound (2:1) with the frequency of 0.8 MHz and intensity of 1.5 W/CM for 10 minutes was dynamically administered for the patients in 10 every other day sessions. 2. Therapeutic exercises * Tibialis anterior strengthening (four sets of ten repetitions, with weights of 3 to 5 kg) * Plantar fascia stretching the patient was comfortably sitting on chair with tennis ball under his foot. Then he rolls the ball by moving his foot in forward and backward direction. * Stretching of the gastrocnemius and gastro soleus muscles by standing (standing calf stretch exercise, standing soleus muscle stretch exercise), the Achilles tendon by sitting (towel stretch exercise) , and the plantar fascia on a step (plantar fascia stretch exercise) . Patients were asked to do the exercises for four weeks, 10 times each morning and evening by counting up to 30

Phonophoresis group

1. Patients will receive ultrasound at a frequency of 1.0 Hz and intensity of 1.2 watts/cm². Ten sessions were undertaken at a frequency of two sessions per week. 2. therapeutic exercises.

ultrasound only and Therapeutic exercises

Eligibility Criteria

Age18 Years - 44 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-44 years .
  • Patients BMI 18.5 to 24.9 kg / m2.
  • The diagnosis of PF appear clinically according to the history and physical - examination findings of point tenderness at or near the medial calcaneal insertion of the plantar fascia .
  • Diagnosis of plantar fasciitis, with plantar fascia of more than 4 mm thickness as evaluated by ultrasonography.
  • Painful symptoms lasting three months or more .

You may not qualify if:

  • Diabetes mellitus, peripheral neuropathy, vasculitis and vasculopathy.
  • Any pathology in ankle/foot (instability, arthritis, malignancy, acute infection, and skin disorders) .
  • Pregnancy or lactation, coronary artery disease, hypertension, renal diseases and anemia .
  • Atrophy/ scar or skin ulcers at the site of intervention.
  • Patients with allergy to nitrates.
  • Heart pacemaker use .
  • Anticoagulant use and absence of coagulation disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university

Cairo, Cairo Governorate, 11311, Egypt

Location

MeSH Terms

Interventions

Exercise Therapy

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • abeer Abdrahman Mohamed, Phd

    Faculty of physical therapy, Cairo university, Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fouad Sherin Fouad, PhD

CONTACT

Doaa Rafat Al azab, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

March 14, 2026

First Posted

March 18, 2026

Study Start

April 30, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

March 24, 2026

Record last verified: 2026-03

Locations